Market Capitalization of Bafna Pharmaceuticals (BAFNAPH)
As of April 15, 2026, Bafna Pharmaceuticals (BAFNAPH) market capitalisation is ₹314.56 Cr ($34.95M), with 2.37 Cr shares outstanding at a current price of ₹132.49 on NSE, ranking 2203 out of 5362 companies by market cap in our screener. Bafna Pharmaceuticals operates in the Healthcare sector and is classified as a Small Cap stock. Read Bafna Pharmaceuticals dividend policy for the complete payout history and dividend yield track record.
Market Cap History of Bafna Pharmaceuticals (Last 10 Years)
BAFNAPH market capitalisation from year-end NSE closing prices over the last 10 years. For live price, earnings and the complete company profile, see Bafna Pharmaceuticals share price chart.
End of Year Market Cap History — Bafna Pharmaceuticals
BAFNAPH year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Analyse Bafna Pharmaceuticals shareholding analysis to track promoter, FII and institutional holdings.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹314.56 Cr
$34.95M USD
|
₹132.49 | NSE | +12.27% |
| 2025 |
₹280.18 Cr
$31.13M USD
|
₹118.01 | NSE | +49.57% |
| 2024 |
₹187.33 Cr
$20.81M USD
|
₹78.90 | NSE | -14.24% |
| 2023 |
₹218.43 Cr
$24.27M USD
|
₹92.00 | NSE | -8.68% |
| 2022 |
₹239.20 Cr
$26.58M USD
|
₹100.75 | NSE | -33.96% |
| 2021 |
₹362.19 Cr
$40.24M USD
|
₹152.55 | NSE | -10.71% |
| 2020 |
₹405.63 Cr
$45.07M USD
|
₹170.85 | NSE | - |